MediSapiens Gets $ 1 Million for World’s First Personalized Cancer Medicine Software

HELSINKI, June 1, 2010 – MediSapiens, world's first software company for personalized
cancer medicine in oncology clinics and drug development, completed
$ 1 million (EUR 0.8 million) seed round investment from Veraventure, ETFIII
advised by Eqvitec Partners, VTT Ventures and Lifeline Ventures.

MediSapiens is based on scientific research at the VTT
Technical Research Centre of [...]

Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus

Acquisition Bolsters Pulmonary Portfolio and Capabilities, Accessing Promising Pipeline of First-in-Class Compounds and Renowned Team of Respiratory Scientists

HORSHAM, Pennsylvania, June 1, 2010 – Centocor Ortho Biotech Inc. today announced that it has acquired
RespiVert Ltd., a privately held drug discovery company focused on developing
small-molecule, inhaled therapies for the treatment of pulmonary diseases.
The company's lead compounds, [...]

Novartis Disappointed by Initial NICE Decision on Xolair(R) (omalizumab)[1] and Concerned that Children Suffering from Severe Persistent Allergic Asthma will be Denied Access to Treatment[1]

FRIMLEY, England, June 1, 2010 -

– Just for UK media, not for Ireland

– This release is intended for consumer media

– Add-On Omalizumab Reduces the Rate of Asthma Attacks in
Children Aged 6 to 11 Years With Severe [...]